Reversibility of hepatic fibrosis and cirrhosis - Is it all hype?

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 4, Issue 5, 2007, Pages 236-237

  Friedman, Scott L ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; SALAZOSULFAPYRIDINE;

CHRONIC LIVER DISEASE; DISEASE COURSE; DISEASE MODEL; DRUG EFFICACY; HEPATITIS B; HEPATITIS C; HISTOLOGY; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; NONHUMAN; PORTAL HYPERTENSION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REMISSION; REVIEW; SCORING SYSTEM;

ANIMALS; DISEASE PROGRESSION; HUMANS; LIVER CIRRHOSIS; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER DISEASES; PROGNOSIS; TIME FACTORS;

EID: 34248196592     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0813     Document Type: Review

References (10)

1. British Broadcasting Corporation, London (2006) Drug 'may reverse liver disease'. [http://news.bbc.co.uk/2/hi/health/5382172.stm] (accessed 22 March 2007)
2. Bonis PA et al. (2001) Is liver fibrosis reversible? N Engl J Med 344: 452-454
3. Nagula S et al. (2006) Histological-hemodynamic correlation in cirrhosis - a histological classification of the severity of cirrhosis. J Hepatol 44: 111-117
4. Issa R et al. (2004) Spontaneous recovery from micronodular cirrhosis: Evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology 126: 1795-1808
5. Herold C et al. Quantitative testing of liver function in relation to fibrosis in patients with chronic hepatitis B and C. Liver 21: 260-265
6. Ratziu V et al. (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128: 1898-1906
7. Gawrieh S et al. (2005) Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation. Liver Transpl 11: 1207-1213
8. Foucher J et al. (2006) Diagnosis of cirrhosis by transient elastography (FibroScan): A prospective study. Gut 55: 403-408
9. Ngo Y et al. (2006) A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem 52: 1887-1896
10. Huang H et al. (2006) Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. Gastroenterology 130: 1679-1687